PUBLISHER: The Business Research Company | PRODUCT CODE: 1713489
PUBLISHER: The Business Research Company | PRODUCT CODE: 1713489
An amnion patch is a medical device made from the amniotic membrane, commonly used in surgeries and wound care. It takes advantage of the natural properties of the amniotic membrane, including its anti-inflammatory and regenerative factors, to aid in healing and tissue repair. Typically, the patch is placed on wounds or surgical sites to facilitate recovery, minimize scarring, and support tissue regeneration.
The main types of amnion patches include transplantation-grade amnion patches, transplantation-grade amnion or chorion patches, and suspension liquid amnio patches. Transplantation-grade amnion patches are high-quality patches designed specifically for use in medical transplant procedures. These patches find applications in corneal repair, ocular surface reconstruction, amniotic membrane transplantation, dental procedures, wound healing, and orthopedic treatments. They are utilized by a range of end-users, including hospitals, eye banks, clinics, and research institutes.
The amnion patch market research report is one of a series of new reports from The Business Research Company that provides amnion patch market statistics, including amnion patch industry global market size, regional shares, competitors with a amnion patch market share, detailed amnion patch market segments, market trends and opportunities, and any further data you may need to thrive in the amnion patch industry. This amnion patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The amnion patch market size has grown strongly in recent years. It will grow from $1.76 billion in 2024 to $1.91 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising incidence of chronic wounds and burns, improving healthcare infrastructure, growing preference for natural and biologic products, increased use in chronic pain management, and increased awareness and education campaigns.
The amnion patch market size is expected to see strong growth in the next few years. It will grow to $2.6 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to growing awareness and acceptance of biological products, increasing surgical procedures, growing focus on minimally invasive treatments, rising prevalence of diabetes, and increasing use of amnion patches in veterinary medicine. Major trends in the forecast period include advancements in regenerative medicine, continuous improvements in the processing and application techniques of amnion patches, increased research and development activities, advancements in biomaterial science, and integration of digital health technologies.
The increasing prevalence of corneal diseases is expected to drive the growth of the amnion patch market in the future. Corneal diseases encompass various disorders that impact the cornea, the clear, front part of the eye responsible for focusing light onto the retina. Factors contributing to the rise in corneal diseases include heightened exposure to environmental stressors and an increase in chronic conditions such as dry eye disease and diabetes. Amnion patches are utilized to aid healing, reduce inflammation, and prevent scarring in damaged or diseased corneal tissue. For example, in October 2022, the World Health Organization reported that 125 million people live in areas endemic to trachoma and are at risk of blindness from the disease. In 2021, 69,266 individuals underwent surgical treatment for advanced stages of trachoma, while 64.6 million received antibiotic treatment. This growing prevalence of corneal diseases is fueling the expansion of the amnion patch market.
Leading companies in the amnion patch market are concentrating on developing advanced products, such as allografts, to enhance their market position. Allografts are tissue grafts taken from a donor and transplanted into a genetically non-identical recipient of the same species. For example, in February 2022, Amnio Technology, a US-based developer of amnion-derived technologies, introduced two new PalinGen membrane products, the PalinGen Dual-Layer Membrane and the Dual-Layer PalinGen X-Membrane. These allografts, part of the PalinGen product line, are minimally manipulated, intended for homologous use, and free of chorion. They are designed for patients with non-healing acute and chronic wounds, as well as complex, open surgical wounds and burns.
In September 2023, Globus Medical, Inc., a US-based medical device company, merged with NuVasive to create a leading global entity in spine and orthopedic care. This merger combines their global reach, expanded commercial capabilities, comprehensive product portfolios, and dedication to product development, surgeon education, and operational excellence. NuVasive, Inc. is also a US-based medical device company.
Major companies operating in the amnion patch market are Zimmer Biomet Holdings Inc., Enovis, Integra LifeSciences Corporation, Globus Medical, BioHorizons, HMP Global Inc., AlloSource, Bio-Tissue Inc., Infinity Biologics Inc., VIVEX Biologics Inc., Tissue Regenix Ltd, Tides Medical, Ritter Implants, Celularity, Spartan Medical Inc., Royal Biologics, ExtremityCare, NuVision Biotherapies Ltd, SurgiLogix, Olifant Biologics, MTF Biologics, BioHealing
North America was the largest region in the amnion patch market in 2024. The regions covered in the amnion patch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the amnion patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The amnion patch market consists of sales of amniotic fluid injections, amnion patch dressings, and amniotic membrane grafts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Amnion Patch Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on amnion patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for amnion patch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The amnion patch market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.